The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medartis Holding AG
OTC:MDRSF
|
CH |
|
Lighthouse Properties PLC
F:87O
|
MT |
|
R
|
Radiopharm Theranostics Ltd
OTC:RDPTF
|
AU |
|
T
|
Tidewater Renewables Ltd
F:7GZ
|
CA |
|
C
|
C Site Co Ltd
KOSDAQ:109670
|
KR |
|
T
|
Texas Roadhouse Inc
F:ROW
|
US |
|
A
|
AI/ML Innovations Inc
XMUN:42FB
|
CA |
|
Mpact Ltd
OTC:MPPTF
|
ZA |
|
D
|
Domo Inc
F:1ON
|
US |
|
P
|
Powertech Technology Inc
TWSE:6239
|
TW |
|
R
|
RTG Mining Inc
ASX:RTG
|
AU |
|
Ranchero Gold Corp
OTC:RNCHF
|
CA |
|
F
|
Fort St James Nickel Corp
OTC:OARFF
|
CA |
|
Bewhere Holdings Inc
OTC:BEWFF
|
CA |
|
T
|
Transcom SA
XBSE:TRVM
|
RO |
|
U
|
United Distributors Pakistan Ltd
KAR:UDPL
|
PK |
|
C
|
Cheryong Electric Co Ltd
KOSDAQ:033100
|
KR |
|
N
|
Neurophet Inc
KOSDAQ:380550
|
KR |
|
E
|
Enerflex Ltd
SWB:7EX
|
CA |
|
T
|
T&D Holdings Inc
DUS:TZ6
|
JP |
|
Ennogie Solar Group A/S
F:B0W
|
DK |
|
S
|
Sinotrans Ltd
XMUN:SIY
|
CN |
|
T
|
Thermax Limited
BSE:500411
|
IN |
|
S
|
Standard Industries Ltd
NSE:SIL
|
IN |
Medartis Holding AG (MDRSF)’s 12-month stock price forecast through October 2027 has a consensus target of $148.4, implying 29% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
MDRSF is 148.4 USD with a low forecast of 146.24 USD and a high forecast of 153.5 USD.
Over the last 9 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 9%.
Over the last 9 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 18%.
Over the last 9 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 15%.
Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 57%.
Over the last 9 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 70%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more